(Q38752816)

6 September 2017

title

Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition (English)

1 reference

6 September 2017

0 references

0 references

1 reference

Zhiyuan Peng

1

1 reference

6 September 2017

Ting Ouyang

2

1 reference

6 September 2017

Daxin Pang

3

1 reference

6 September 2017

Teng Ma

4

1 reference

6 September 2017

Xinrong Chen

5

1 reference

6 September 2017

Ning Guo

6

1 reference

6 September 2017

Fuwang Chen

7

1 reference

6 September 2017

Lin Yuan

8

1 reference

6 September 2017

Hongsheng Ouyang

9

1 reference

6 September 2017

Linzhu Ren

10

1 reference

6 September 2017

publication date

6 August 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

223

1 reference

6 September 2017

page(s)

197-205

1 reference

Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Development of broad virus resistance in non-transgenic cucumber using CRISPR/Cas9 technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

A dark-to-bright reporter cell for classical swine fever virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Cas9 specifies functional viral targets during CRISPR-Cas adaptation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Development and applications of CRISPR-Cas9 for genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Analysis of myostatin and its related factors in various porcine tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Targeting hepatitis B virus cccDNA using CRISPR/Cas9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Pseudorabies virus in wild swine: a global perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

A multiple SYBR Green I-based real-time PCR system for the simultaneous detection of porcine circovirus type 2, porcine parvovirus, pseudorabies virus and Torque teno sus virus 1 and 2 in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Genome engineering using the CRISPR-Cas9 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

In vivo genome editing using Staphylococcus aureus Cas9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Targeting Hepatitis B Virus With CRISPR/Cas9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Herpesviruses--a zoonotic threat?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

HMG-CoA reductase is negatively associated with PCV2 infection and PCV2-induced apoptotic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

Pathogenic pseudorabies virus, China, 2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9 for genome editing: progress, implications and challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.08.001

10.1016/J.VIRUSRES.2016.08.001

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference